Emergent BioSolutions announces brincidofovir trial in Africa
The Fly

Emergent BioSolutions announces brincidofovir trial in Africa

Emergent BioSolutions (EBS) announced that brincidofovir will be included in a clinical trial conducted and sponsored by Panther, under the leadership of the Africa Centres for Disease Control and Prevention, as part of the ‘MpOx Study in Africa’. The study will evaluate the safety and efficacy of brincidofovir in treating mpox virus in a randomized double-blind placebo-controlled trial.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App